After defending Houston Dr. Stella Immanuel for touting hydroxychloroquine, President Trump abruptly ended a press conference at the White House on Tuesday.
According to Fox News, this is just hours after Twitter deleted Trump’s retweet of a video showing Immanuel speaking about the drug.
Trump retweeted a video on Monday, showing several doctors including Immanuel. In the video, Immanuel said, “Nobody needs to get sick. … This virus has a cure.” The doctors in the video were also suggesting that schools do not need to remain closed. Twitter, YouTube, and Facebook removed the video after millions of views.
Breaking News Alert: Facebook Is Suppressing Politically Conservative Content. Join PatriotPlanet.com Today and Let Your Voice Be Heard.
Immanuel also said that we do not need to wear protective masks.
Reporters Question Trump
Dr Stella is one of hundreds of Drs that prescribe Hydroxychloroquine for covid and adimently approval of it's usefulness for covid…
Trump ends press briefing after defending pro-hydroxychloroquine doctor who says virus has a 'cure'https://t.co/JHiech6UsU
— Texas Barbi 🙏 TRUMP 2020 & BEYOND (@bkayvoight) July 29, 2020
CNN reporter Kaitlan Collins emphasized during the briefing some of Immanuel’s comments in the past.
Journalist Aaron Rupar shared on Twitter some quotes from Collins and Trump: “The woman you say is a ‘great doctor’ said masks don’t work & doctors make medicine using DNA from aliens,” Collins said.
“I can tell you this: She was on air, along with many other doctors, & they were big fans of hydroxychloroquine. I thought she was very impressive,” Trump said.
Under questioning from another reporter, Trump defended his previous positions on hydroxychloroquine. He said he believes it “has an impact” especially in the early stages of coronavirus infection, Fox News reported.
At a White House briefing last March, Trump said: “Now, a drug called chloroquine, and some people would add to it, hydroxychloroquine, so chloroquine or hydroxychloroquine … [has] shown very encouraging, very, very encouraging early results.”
He acknowledged that the drug may not “go as planned” and more testing was needed. However, he said, “we’re going to be able to make that drug available almost immediately.”